国际标准期刊号: 2278-0238

国际药学与生命科学研究与发展杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

A Review on 3D Oral Printed Tablets: A Breakthrough Tool for Individualized Therapy According To Each Patient's Individual Circumstances with Different Techniques and Polymers Used For Formulation

Pujan V. Padsala, Harmish A Asodariya, Yash S Shah, Dip Ranpariya, Dr. Hiral Panchal

When treating patients from various origins with distinct cultures, metabolisms, and needs, interindividual variability is becoming a more widespread concern. Because dose modification typically relies on empirical techniques, there is a strong probability that undesirable side effects may manifest.The pharmaceutical industry is being revolutionized by three-dimensional (3D) printed pharmaceuticals as prospective instruments to create individualized therapies tailored to each patient's unique needs,taking into consideration their age, weight,pharmacogenetic,comorbidities, pharmacogenetic,and pharmacokinetic features. Only three of the various processes used in additive manufacturing, or 3D printing, are primarily employed in the 3D printing of pharmaceuticals: printing-based inkjet systems, nozzle-based deposition systems, and laser-based writing systems. Each method has a number of downsides, and the kinds of polymers thatare easily accessible don't necessarily have the best qualities for each medicine. The purpose of this study is to provide an overview of the current methods used in 3D printing medications, highlighting their advantages and shortcomings as well as the necessary polymers and medications for a successful print. Also covered will be the main applications
of these approaches.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。